DOI: 10.1001/jama.2026.6918 ISSN: 0098-7484

Antiviral Therapies for Adults With Mild to Moderate COVID-19 Infection

Peggy B. Leung, Andrew M. Davis, Kristen M. Marks

This JAMA Clinical Guidelines Synopsis summarizes the 2025 Infectious Diseases Society of America (IDSA) updated recommendations on antiviral treatment for mild to moderate COVID-19 in adults.

More from our Archive